Site-specific acetylation of p53 directs selective transcription complex assembly.

Histone deacetylase (HDAC) inhibitors are being investigated as possible adjuvant therapies for a number of diseases, including cancer. In addition to stabilization of acetylated histones, HDAC inhibitors stabilize the acetylation of a number of transcription factors, including p53. This study investigates the action of two HDAC inhibitors, CG-1521 and trichostatin A, which stabilize Ac-Lys-373 p53 and Ac-Lys-382 p53, respectively, in LNCaP prostate cancer cells. Real-time PCR demonstrates that CG-1521 induces p21 transcription whereas trichostatin A does not alter the steady state level of p21 mRNA. Co-immunoprecipitation demonstrates that the selective acetylation of p53 directs the recruitment of mutually exclusive coactivator complexes on the p53 response elements in the p21 promoter. Furthermore, the co-activator complexes initiate the recruitment of the components of the basal transcription apparatus to the basal promoter with markedly different outcomes because only Ac-Lys-373 p53 promotes the assembly of the basal transcriptional apparatus on the p21 promoter. These data highlight the profound effects of post-translational modification, including acetylation, on the function of p53. The data also suggest a novel and critically important role for protein acetylation/deacetylation in the assembly of active transcription processes that may be as important as classical phosphorylation/dephosphorylation.
AuthorsSomdutta Roy, Martin Tenniswood
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 282 Issue 7 Pg. 4765-71 (Feb 16 2007) ISSN: 0021-9258 [Print] United States
PMID17121856 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • RNA, Messenger
  • RNA, Neoplasm
  • Tumor Suppressor Protein p53
  • trichostatin A
  • Histone Deacetylases
  • Acetylation
  • Cell Line, Tumor
  • Chemotherapy, Adjuvant
  • Cyclin-Dependent Kinase Inhibitor p21 (biosynthesis)
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases (metabolism)
  • Histones (metabolism)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Male
  • Promoter Regions, Genetic
  • Prostatic Neoplasms (drug therapy, metabolism)
  • Protein Processing, Post-Translational
  • RNA, Messenger (metabolism)
  • RNA, Neoplasm (metabolism)
  • Transcription, Genetic (drug effects)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: